Methods to evaluate the performance of a multicomponent meningococcal serogroup B vaccine

Methods to evaluate the performance of a multicomponent meningococcal serogroup B vaccine

ABSTRACT Meningococcal serogroup B (MenB) vaccine licensure was based on the assessment of vaccine-induced immune responses by human serum bactericidal antibody (hSBA) assay against a small number of antigen-specific strains complemented by strain coverage predictions. However, the evaluation of vac...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ray Borrow, Laura Tomasi Cont, Daniela Toneatto, Stefania Bambini, Shravani Bobde, Woo-Yun Sohn, Alessia Biolchi, Vega Masignani, Peter T. Beernink, Maria Lattanzi
Format:	Article
Language:	English
Published:	American Society for Microbiology 2025-04-01
Series:	mSphere
Subjects:	4CMenB invasive meningococcal disease Neisseria meningitidis serum bactericidal antibody assay vaccine vaccine effectiveness
Online Access:	https://journals.asm.org/doi/10.1128/msphere.00898-24
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Genetic characterization and estimated 4CMenB vaccine strain coverage of 284 Neisseria meningitidis isolates causing invasive meningococcal disease in Argentina in 2010–2014
by: Adriana Efron, et al.
Published: (2024-12-01)

Bactericidal killing of meningococcal W strains isolated in Argentina by the sera of adolescents and infants immunized with 4-component meningococcal serogroup B vaccine (4CMenB)
by: Adriana Efron, et al.
Published: (2023-12-01)

4CMenB journey to the 10-year anniversary and beyond
by: Véronique Abitbol, et al.
Published: (2024-12-01)

Available evidence on the co-administration of the four-component meningococcal B vaccine (4CMenB) with three vaccines at the same visit among pediatric individuals
by: Paolo Bonanni, et al.
Published: (2024-12-01)

Exploring the sequence diversity and surface expression of Factor H-Binding Protein among invasive serogroup B meningococcal strains from selected European countries
by: Stephen A. Clark, et al.
Published: (2024-12-01)

The immunogenicity and safety of an investigational meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine (ACWY-TT) compared with a licensed meningococcal tetravalent polysaccharide vaccine<subtitle>A randomized, controlled non-inferiority study</subtitle>
by: Ghassan Dbaibo, et al.
Published: (2012-07-01)

Use of 4CMenB vaccine in the control of an outbreak of serogroup B invasive meningococcal disease in an elderly care home, England, November 2023
by: Shamez N Ladhani
Published: (2025-04-01)

EPIDEMIOLOGY AND PREVENTION OF MENINGOCOCCAL DISEASE: A CRITICAL APPRAISAL OF VACCINE POLICIES
by: Marco AP Safadi, et al.
Published: (2012-02-01)

Immunogenicity and safety of meningococcal vaccines, MenACWY-CRM and 4CMenB, in groups at increased risk for meningococcal disease
by: Shravani Bobde, et al.
Published: (2025-12-01)

Genomic characterization of invasive Neisseria meningitidis in Spain (2011/12–2022/23): expansion of clonal complex 213 and the potential threat to 4CMenB vaccine strain coverage
by: Josep Roca-Grande, et al.
Published: (2025-12-01)

Rare generalized form of meningococcal disease caused by Neisseria meningitidis serogroup W
by: L. N. Mazankova, et al.
Published: (2020-03-01)

Meningococcal vaccine 4CMenB elicits a robust cellular immune response that targets but is not consistently protective against Neisseria gonorrhoeae during murine vaginal infection
by: Joseph J. Zeppa, et al.
Published: (2025-05-01)

Meningococcal vaccination disparities in the United States (2010–2021): Findings from the National Immunization Survey-Teen and a commercial insurance database
by: Oscar Herrera-Restrepo, et al.
Published: (2025-12-01)

Joint consensus on reducing the burden of invasive meningococcal disease in the Asia-Pacific region
by: Gang Liu, et al.
Published: (2025-12-01)

Meningococcal meningitis: clinical and laboratorial characteristics, fatality rate and variables associated with in-hospital mortality
by: Vanessa L. Strelow, et al.

Genomic analysis of Neisseria meningitidis serogroup W causing invasive meningococcal disease in four travellers from Saudi Arabia, Italy, 2025
by: Paola Stefanelli
Published: (2025-08-01)

Meningococcal Vaccination in High-Risk Patients: A Systematic Approach to Evaluating Coverage and Patient Catch-Up Through Healthcare Databases
by: Rafael Ruiz-Montero, et al.
Published: (2025-03-01)

Serogroup B Protein Meningococcal Vaccines and the Formation of Immune Protection against Gonorrhea
by: N. N. Kostyukova, et al.
Published: (2024-07-01)

World Experience in the Use Serogroup B Meningococcal Vaccines (literature review)
by: I. S. Koroleva, et al.
Published: (2022-01-01)

Invasive meningococcal disease
by: Vanessa L. Strelow, et al.
Published: (2013-09-01)

Molecular Сharacterization of <i>Neisseria meningitidis</i> Serogroup W in St. Petersburg
by: E. A. MARTENS, et al.
Published: (2022-09-01)

Antibiotic Sensitivity of <i>Neisseria meningitidis</i> Isolated From Patients with Generalized Forms of Meningococcal Infection and From Healthy Carriers
by: E. A. MARTENS, et al.
Published: (2022-09-01)

Meningococcal meningitis complicated by septic shock, myocarditis and purpura fulminans
by: H. M. U. A. S. Perera, et al.
Published: (2025-08-01)

An overview of the meningococcal disease and impact of the quadrivalent meningococcal conjugate vaccine
by: Asmaa Alrobai, et al.
Published: (2021-12-01)

A new quadrivalent meningococcal tetanus toxoid conjugate vaccine: Menquadfi® (MENACWY-TT)
by: Ener Cagri Dinleyici, et al.
Published: (2025-12-01)

Economic Evaluation of Adolescent Vaccination with Serogroup ACWY and C Meningococcal Vaccines in Germany
by: Sebastian Gruhn, et al.
Published: (2025-03-01)

Factor H binding protein (FHbp): An evaluation of genotypic diversity across Neisseria meningitidis serogroups
by: Zhenghui Li, et al.
Published: (2024-12-01)

The investigational meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine (ACWY-TT) and the seasonal influenza virus vaccine are immunogenic and well-tolerated when co-administered in adults
by: Mari Rose Aplasca-De Los Reyes, et al.
Published: (2012-07-01)

Meningococcal Sepsis in Patient with Paroxysmal Nocturnal Hemoglobinuria during Pegcetacoplan Therapy
by: Leo Starck, et al.
Published: (2025-03-01)

Characterization of Unusual Serogroups of <i>Neisseria meningitidis</i>
by: Samy Taha, et al.
Published: (2024-12-01)

Immunity Dynamics of <i>Neisseria meningitidis</i> Serogroups ACYW from Birth and Following Vaccination
by: Lilian Zeng, et al.
Published: (2024-11-01)

Invasive Meningococcal Disease in Children: Outcomes and Risk Factors for Sequelae and Fatal Cases in Greece
by: Panagiotis Poulikakos, et al.
Published: (2025-03-01)

Current methods in the diagnosis of invasive meningococcal disease
by: Ergin Ciftci, et al.
Published: (2025-04-01)

Meningococcal B Vaccines as a Paradigm of Safe and Effective Vaccines for Children
by: Maribel Gonzalez Tome, et al.
Published: (2025-07-01)

Epidemiological characteristics of invasive meningococcal disease and carriage prevalence of Neisseria meningitidis in the Xinjiang Uygur Autonomous Region, China, 2004–2023: a retrospective study
by: Halimubieke Nazhaerbieke, et al.
Published: (2025-07-01)

Meningococcal C Disease Outbreak Caused by Multidrug-Resistant Neisseria meningitidis, Fiji
by: Aneley Getahun Strobel, et al.
Published: (2025-01-01)

4CMenB vaccine coverage of invasive serogroup B meningococci collected in Belgium between 2016 and 2022
by: Nathalie Goeders, et al.
Published: (2025-12-01)

Meningococcal Carriage: Epidemiology, Causative Agent, Inducing of Immune Protection
by: N. N. Kostyukova, et al.
Published: (2017-10-01)

Encefalomielite disseminada aguda e vacinação antimeningocócica A e C: relato de caso Acute disseminated encephalomyelitis: association with meningococcal A and C vaccine: case report
by: Marco O. Py, et al.
Published: (1997-09-01)

Primary (isolated) meningococcal pericarditis caused by <i>N. meningitidis</i>: case report
by: O. O. Chernysheva, et al.
Published: (2025-03-01)